Association between the C-reactive protein–triglyceride–glucose index and coronary heart disease in metabolic dysfunction-associated steatotic liver disease patients: a cross-sectional study - Takeaways - MDSpire

Association between the C-reactive protein–triglyceride–glucose index and coronary heart disease in metabolic dysfunction-associated steatotic liver disease patients: a cross-sectional study

  • By

  • Kaiyue Shen

  • Jiajia Zhao

  • Kunkun Li

  • Lidong Xu

  • Huili Wu

  • July 7, 2026

  • 0 min

Share

  • 1

    The study involved 611 patients with metabolic dysfunction-associated steatotic liver disease (MASLD) who underwent coronary angiography.

  • 2

    C-reactive protein–triglyceride–glucose index (CTI) was independently associated with coronary heart disease (CHD) presence and severity.

  • 3

    Among participants, 63.3% had CHD, with higher CTI levels correlating to greater coronary stenosis severity.

  • 4

    CTI demonstrated superior discriminative ability for CHD compared to other simple insulin resistance indices.

  • 5

    A nomogram incorporating CTI and other factors was developed, achieving an AUC of 0.845 for CHD discrimination.

Original Source(s)

Association between the C-reactive protein–triglyceride–glucose index and coronary heart disease in metabolic dysfunction-associated steatotic liver disease patients: a cross-sectional study

  • by Kaiyue Shen, Jiajia Zhao, Kunkun Li, Lidong Xu, Huili Wu

  • July 7, 2026

Related Content

Biochanin A attenuates doxorubicin-induced cardiotoxicity in rats with associated modulation of PI3K/Akt/mTOR and p38 MAPK signaling

Thrombus straddling the patent foramen ovale: a case report

Association between obstructive sleep apnea syndrome and blood pressure variability: a meta-analysis